2014-04144. Advisory Committees; Filing of Closed Meeting Reports  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that, as required by the Federal Advisory Committee Act, the Agency has filed with the Library of Congress the annual reports of those FDA advisory committees that held closed meetings during fiscal year 2013.

    ADDRESSES:

    Copies are available from the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 301-827-6860.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Teresa L. Hays, Committee Management Officer, Advisory Committee and Oversight Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-8220.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under section 10(d) of the Federal Advisory Committee Act (5 U.S.C. app.) and 21 CFR 14.60(d), FDA has filed with the Library of Congress the annual reports for the following FDA advisory committees that held closed meetings during the period October 1, 2012, through September 30, 2013:

    Center for Biologics Evaluation and Research

    Blood Products Advisory Committee, Cellular, Tissue, and Gene Therapies Advisory Committee, Vaccines and Related Biological Products Advisory Committee.

    National Center for Toxicological Research

    Science Board to the National Center for Toxicological Research.

    Center for Tobacco Products

    Tobacco Products Scientific Advisory Committee.

    Annual reports are available for public inspections between 9 a.m. and 4 p.m., Monday through Friday at the following locations:

    (1) The Library of Congress, 101 Independence Ave. SE., James Madison Memorial Bldg., Newspaper and Current Periodical Reading Room, Rm. 133, Washington, DC 20540; and

    (2) The Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    Start Signature

    Dated: February 21, 2014.

    Jill Hartzler Warner,

    Acting Associate Commissioner for Special Medical Programs.

    End Signature End Supplemental Information

    [FR Doc. 2014-04144 Filed 2-25-14; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Published:
02/26/2014
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice
Document Number:
2014-04144
Pages:
10814-10814 (1 pages)
Docket Numbers:
Docket No. FDA-2014-N-0001
PDF File:
2014-04144.pdf
Supporting Documents:
» Closed Meeting Report from FDA/OC